Immunovant Doubles — And Slugs Argenx

said Tuesday its drug lowered a key antibody in healthy people, signaling it could treat a myriad autoimmune conditions, and IMVT stock launched to a two-year high. The company tested its drug, known as IMVT-1402, in healthy adults. The experimental under-the-skin shot led to dose-dependent…#imvt1402 #albumin #immunovant #igg #leerinkpartners #thomassmith #argenx #argx #vyvgart #cidp

Source: Reuters: Health - September 26, 2023 Category: Consumer Health News Source Type: news